• 1  Horny HP, Metcalfe DD, Bennett JM, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. Lyon, France: IARC Press, 2008:54–63.
  • 2  Nettleship E, Tay W. Rare forms of urticaria. BMJ 1869;ii:323–30.
  • 3  Sangster A. An anomalous mottled rash, accompanied by pruritus, factitious urticaria and pigmentation, ‘urticaria pigmentosa (?)’. Trans Clin Soc London 1878;11:161–3.
  • 4  Parr MM, Sézary A, Lévy‐Coblentz G, Chauvillon P. Dermographisme et mastocytose. Bull Soc Fr Dermatol Syphilol 1936;43:359–61.
  • 5  Valent P, Akin C, Escribano M, et al. Standards and standarization in mastocytosis: consensus statements on diagnostics. Treatment recommendations and response criteria. Eur J Clin Investig 2007;37:435–53. Cross Ref link
  • 6  Büttner C, Henz BM, Welker P, et al. Identification of activating c‐kit mutations in adult‐, but not in childhood onset indolent mastocytosis: a possible explanation for divergent clinical behaviour. J Invest Dermatol 1998;111:1227–31. Cross Ref link Pubmed link
  • 7  Longley BJ, Metcalfe DD, Tharp M et al. Activating and dominant inactivating c‐kit catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci USA 1999;96:1609–14. Cross Ref link Pubmed link
  • 8  Bodemer C, Hermine O, Palmérini F, et al. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c‐KIT mutations. J Invest Dermatol 2010;130:804–15. Cross Ref link Pubmed link
  • 9  Brockow K. Epidemiology, prognosis, and risk factors in mastocytosis. Immunol Allergy Clin North Am 2014;34:283–95. Cross Ref link Pubmed link
  • 10  Chang A, Tung RC, Schlesinger T, et al. Familial cutaneous mastocytosis. Pediatr Dermatol 2001;18:271–6. Cross Ref link Pubmed link
  • 11  Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy 2008;63:226–32. Cross Ref link Pubmed link
  • 12  Müller U, Helbling A, Hunziker T, et al. Mastocytosis and atopy: a study of 33 patients with urticaria pigmentosa. Allergy 1990;45:597–603. Cross Ref link Pubmed link
  • 13  Rossini M, Zanotti R, Viapiana O, et al. Bone involvement and osteoporosis in mastocytosis. Immunol Allergy Clin North Am 2014;34:383–96. Cross Ref link Pubmed link
  • 14  Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am 2014;34:207–18. Cross Ref link Pubmed link
  • 15  Garriga MM, Friedman MM, Metcalfe DD. A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. J Allergy Clin Immunol 1988;82:425–32. Cross Ref link Pubmed link
  • 16  Olafsson JH, Roupe G, Enerbäck L. Dermal mast cells in mastocytosis: fixation, distribution and quantitation. Acta Derm Venereol (Stockh) 1986;66:16–22.
  • 17  Pardanani A, Tefferi A. Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature. Curr Opin Hematol 2010;17:125–32. Cross Ref link Pubmed link
  • 18  Azaña JM, Torrelo A, Mediero IG, Zambrano A. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994;11:102–6. Cross Ref link Pubmed link
  • 19  Nagayo K, Sakai M, Mizuno N. Juvenile xanthogranuloma with Darier's sign. J Dermatol 1983;10:283–5. Cross Ref link Pubmed link
  • 20  Yen A, Sanchez R, Oblender M, Raimer S. Leukemia cutis: Darier's sign in a neonate with acute lymphoblastic leukaemia. J Am Acad Dermatol 1996;34:375–8. Cross Ref link Pubmed link
  • 21  Topar G, Staudacher C, Geisen F, et al. Urticaria pigmentosa: a clinical, haematopathological and serologic study of 30 adults. Am J Clin Pathol 1998;109:279–85. Cross Ref link Pubmed link
  • 22  Czarnetzki BM, Kolde G, Schoemann A, et al. Bone marrow findings in adult patients with urticaria pigmentosa. J Am Acad Dermatol 1988;18:45–51. Cross Ref link Pubmed link
  • 23  Tebbe B, Stavropoulos PG, Krasagakis K, Orfanos CE. Cutaneous mastocytosis in adults: evaluation of 14 patients with respect to systemic disease manifestations. Dermatology 1998;197:101–8. Cross Ref link Pubmed link
  • 24  Brockow K, Scott LM, Worobec AS, et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis. Arch Dermatol 2002;138:785–90. Cross Ref link Pubmed link
  • 25  Marrouche N, Grattan C. TMEP or not TMEP: That is the question. J Am Acad Dermatol 2014;70:581–2. Cross Ref link Pubmed link
  • 26  Johnson EC, Helwig EB. Solitary mastocytosis (urticaria pigmentosa). Arch Dermatol 1961;84:806–15. Cross Ref link Pubmed link
  • 27  Birt AR, Nickerson M. Generalized flushing of the skin with urticaria pigmentosa. Arch Dermatol 1959;80:311–17. Cross Ref link
  • 28  Stein DH. Mastocytosis: a review. Pediatr Dermatol 1986;3:365–75. Cross Ref link Pubmed link
  • 29  Valent P, Escribano L, Broesby‐Olsen S et al. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis. Allergy 2014;69:1267–74, doi: 10.1111/all.12436. Cross Ref link Pubmed link
  • 30  Akin C. Mast cell activation disorders. J Allergy Clin Immunol Pract 2014;2:252–7. Cross Ref link Pubmed link
  • 31  Webber NK, Ponnampalam J, Grattan CEH. How reliable is blood tryptase as a marker of systemic disease in an infant with cutaneous mastocytomas? Clin Exp Dermatol 2008;33:198–9. Cross Ref link Pubmed link
  • 32  Kristensen T, Broesby‐Olsen S, Vestergaard H, Bindslev‐Jensen C, Moller MB. Circulating KIT D816V mutation positive non‐mast cells in peripheral blood are characteristic of indolent systemic mastocytosis. Eur J Harmatol 2012;89:42–6. Cross Ref link
  • 33  Erben P, Schwaab J, Metzgeroth G, et al. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis. Ann Haematol 2014;93:81–8. Cross Ref link
  • 34  Lim KH, Tefferi A, Lasho TL, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009;113:5727–36. Cross Ref link Pubmed link
  • 35  Fricker M, Helbling A, Schwartz L, Müller U. Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and the results of immunotherapy in ten patients. J Allergy Clin Immunol 1997;100:11–15. Cross Ref link Pubmed link
  • 36  Vaughan STA, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia 1998;53:804–7. Cross Ref link Pubmed link
  • 37  Royal College of Anaesthetists. Mastocytosis and anaesthesia, Advice for patients. Royal College of Anaesthetists, 2014 http://www.rcoa.ac.uk/system/files/MASTOCYTOSIS‐2014_0.pdf (last accessed June 2015).
  • 38  Horan RF, Sheffer AL, Austen KF. Cromolyn sodium in the management of systemic mastocytosis. J Allergy Clin Immunol 1990;85:852–5. Cross Ref link Pubmed link
  • 39  Vella Briffa D, Eady RAJ, James MP, et al. Photochemotherapy (PUVA) in the treatment of urticaria pigmentosa. Br J Dermatol 1983;109:67–75. Cross Ref link Pubmed link
  • 40  Kolde G, Frosch PJ, Czarnetzki BM. Response of cutaneous mast cells to PUVA in patients with urticaria pigmentosa: histomorphometric, ultrastructural and biochemical investigations. J Invest Dermatol 1984;83:175–8. Cross Ref link Pubmed link
  • 41  Barton J, Lavker RM, Schechter NM, Lazarus GS. Treatment of urticaria pigmentosa with corticosteroids. Arch Dermatol 1985;121:1516–23. Cross Ref link Pubmed link
  • 42  Czarnetzki BM, Algermissen B, Jeep S, et al. Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30:500–1. Cross Ref link Pubmed link
  • 43  Hübner C, Wedding U, Sträter J, et al. Clinical stable systemic mastocytosis treated with interferon alpha‐2b therapy. J Intern Med 1997;241:529–33. Pubmed link
  • 44  Kluin‐Nelemans HC, Oldhoff JM, Van Doormaal JJ, et al. Cladribine therapy for systemic mastocytosis. Blood 2003;102:4270–6. Cross Ref link Pubmed link
  • 45  Gotlib J, Kluin‐Nelemans HC, George TI, et al. KIT inhibitor midostaurin in patients with advanced systemic mastocytosis: results of a planned interim analysis of the global CPKC412D2201 trial. Blood 2012;120:799.
  • 46  Azãna JM, Torrelo A, Mediero IG, Zambrano A. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994;11:102–6. Cross Ref link Pubmed link
  • 47  Topar G, Staudacher C, Geisen F, et al. Urticaria pigmentosa: a clinical, hematopathologic and serologic study of 30 adults. Am J Clin Pathol 1998;109:279–85. Cross Ref link Pubmed link
  • 48  Brockow K, Scott LM, Worobec AS, et al. Regression of urticaria pigmentosa in adult patients with systemic mastocytosis. Correlation with clinical patterns of disease. Arch Dermatol 2002;138:785–90. Cross Ref link Pubmed link